Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103626630B reveals a cost-effective Rivaroxaban intermediate synthesis. Enhances supply chain reliability and reduces manufacturing能耗 for pharmaceutical partners.
Patent CN101717392A details a novel rotigotine synthesis using chiral phosphoric acid resolution, offering high optical purity and cost reduction in API manufacturing.
Patent CN103626630B reveals a novel catalytic hydrogenation route for Rivaroxaban intermediates, offering significant cost reduction and scalable high-purity manufacturing for global supply chains.
Novel patent CN110028461A enables high-purity candesartan cilexetil production with improved supply chain stability and significant cost efficiency for global buyers.
Patent CN104844476B reveals advanced biphenyl synthesis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel synthetic route for fexofenadine avoiding isomer separation. High yield, simple process, cost-effective manufacturing for pharmaceutical intermediates.
Advanced semi-synthetic route for Paclitaxel and Docetaxel offering high yield and purity. Optimized for cost reduction in API manufacturing and supply chain stability.
Patent CN102617312B reveals a greener synthesis route for 2-chloro-6-fluorobenzaldehyde using ferric solid superacid, offering significant cost reduction and higher purity for API intermediates.
Patent CN110483346B reveals a visible-light photocatalytic method for synthesizing sulfonyl-substituted alpha-cyclopropyl styrenes, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN103351361B details a novel Pd-catalyzed oxidation route for Levocetirizine Dihydrochloride ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN101870703B details a novel disulfide porphyrin catalyst enabling efficient aerobic oxidation. Discover cost-effective manufacturing and supply chain advantages.
Novel industrial method for Dasatinib synthesis avoiding palladium catalysts, offering cost reduction and scalable production for pharmaceutical manufacturers.
Patent CN111423320A reveals a green synthesis of nervonic acid using Grignard reactions, offering high purity pharmaceutical intermediates with reduced environmental impact.
Novel one-pot synthesis using PEG-400 solvent offers high yield and green chemistry advantages for scalable pharmaceutical intermediate manufacturing.
Patent CN115385971A details a novel NMN preparation method using phosphorus pentoxide to eliminate arsenic residues and reduce wastewater phosphorus for cost-effective manufacturing.
Patent CN114478580A reveals a recyclable ionic liquid method for synthesizing pyrano thiazolo pyrimidine derivatives, offering high purity and reduced waste for API manufacturing.
Patent CN102746360B details novel camptothecin-steroid conjugates with enhanced antitumor activity. Discover cost-effective EDCI-DMAP synthesis routes for high-purity API intermediates.
Novel patent CN117567311A offers efficient ceramide preparation with simplified post-treatment and high purity for cosmetic and pharmaceutical applications.
Advanced patent CN104016954A method for nebivolol intermediate. High yield, >99% purity, scalable process for reliable pharmaceutical intermediate supplier.
Advanced NCP ligand iridium complexes enable efficient alkane dehydrogenation and α-alkylation with high selectivity and stability for industrial scale-up.